This downregulation was associated with the strong promoter methylation of the CB1R gene, suggesting that elevated levels of endogenous cannabinoids might not affect tumor growth because the loss of CB1R in most CRC cases would render the cells resistant to these ligands. The gene discussed is CNR1; the disease is neoplasm.